Fyn is required for haloperidol-induced catalepsy in mice

Journal of Biological Chemistry

Volumn 281, Issue 11, 2006, Pages 7129-7135

  Hattori, Kotaro ^a,b,c,d   Uchino, Shigeo ^a   Isosaka, Tomoko ^a,c,d   Maekawa, Mamiko ^b   Iyo, Masaomi ^b   Sato, Toshio ^b   Kohsaka, Shinichi ^a   Yagi, Takeshi ^c,d,e   Yuasa, Shigeki ^a,b  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; ETHANOL; NEUROLOGY; PROTEINS;

ANTIPSYCHOTICS; CATALEPSY; HALOPERIDOL; N-METHYL-D-ASPARTATE (NMDA);

BIOMEDICAL ENGINEERING;

CALCIUM; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; L 741616; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEUROLEPTIC AGENT; PROTEIN KINASE FYN; QUINPIROLE; TYROSINE; UNCLASSIFIED DRUG; ANTIPARKINSON AGENT; DOPAMINE; FYN PROTEIN, MOUSE; INDOLE DERIVATIVE; L 741626; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PIPERIDINE DERIVATIVE; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALEPSY; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; EXTRAPYRAMIDAL SYMPTOM; FETUS; GENOTYPE; MOUSE; MUSCLE RIGIDITY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TIME;

ANIMALIA;

ANIMALS; ANTI-DYSKINESIA AGENTS; ANTIPSYCHOTIC AGENTS; BLOTTING, WESTERN; CALCIUM; CATALEPSY; CELLS, CULTURED; DOPAMINE; GENOTYPE; HALOPERIDOL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN SITU HYBRIDIZATION; INDOLES; MICE; NEURONS; PHOSPHORYLATION; PIPERIDINES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-FYN; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; TIME FACTORS; TYROSINE;

EID: 33646344241     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M511608200     Document Type: Article

References (51)

1. Crocker, A. D., and Hemsley, K. M. (2001) Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 573-590
2. Wadenberg, M. L., Soliman, A., VanderSpek, S. C., and Kapur, S. (2001) Neuropsychopharmacology 25, 633-641
3. Moore, N. A., Blackman, A., Awere, S., and Leander, J. D. (1993) Eur. J. Pharmacol. 237, 1-7
4. Chartoff, E. H., Ward, R. P., and Dorsa, D. M. (1999) J. Pharmacol. Exp. Ther. 291, 531-537
5. Chase, T. N. (2004) Parkinsonism Relat. Disord. 10, 305-313
6. Sucher, N. J., Awobuluyi, M., Choi, Y. B., and Lipton, S. A. (1996) Trends Pharmacol. Sci. 17, 348-355
7. Standaert, D. G., Testa, C. M., Young, A. B., and Penney, J. B., Jr. (1994) J. Comp. Neurol. 343, 1-16
8. Kosinski, C. M., Standaert, D. G., Counihan, T. J., Scherzer, C. R., Kerner, J. A., Daggett, L. P., Velicelebi, G., Penney, J. B., Young, A. B., and Landwehrmeyer, G. B. (1998) J. Comp. Neurol. 390, 63-74
9. Yanahashi, S., Hashimoto, K., Hattori, K., Yuasa, S., and Iyo, M. (2004) Brain Res. 1011, 84-93
10. Wang, Y. T., and Salter, M. W. (1994) Nature 369, 233-235
11. Tingley, W. G., Ehlers, M. D., Kameyama, K., Doherty, C., Ptak, J. B., Riley, C. T., and Huganir, R. L. (1997) J. Biol. Chem. 272, 5157-5166
12. Menegoz, M., Lau, L. F., Herve, D., Huganir, R. L., and Girault, J. A. (1995) Neuroreport 7, 125-128
13. Oh, J. D., Russell, D. S., Vaughan, C. L., Chase, T. N., and Russell, D. (1998) Brain Res. 813, 150-159
14. Salter, M. W., and Kalia, L. V. (2004) Nat. Rev. Neurosci. 5, 317-328
15. Miyakawa, T., Yagi, T., Kitazawa, H., Yasuda, M., Kawai, N., Tsuboi, K., and Niki, H. (1997) Science 278, 698-701
16. Yaka, R., Phamluong, K., and Ron, D. (2003) J. Neurosci. 23, 3623-3632
17. Nakazawa, T., Komai, S., Tezuka, T., Hisatsune, C., Umemori, H., Semba, K., Mishina, M., Manabe, T., and Yamamoto, T. (2001) J. Biol. Chem. 276, 693-699
18. Kojima, N., Ishibashi, H., Obata, K., and Kandel, E. R. (1998) Learn. Mem. 5, 429-445
19. Cheung, H. H., and Gurd, J. W. (2001) J. Neurochem. 78, 524-534
20. Yagi, T., Shigetani, Y., Okado, N., Tokunaga, T., Ikawa, Y., and Aizawa, S. (1993) Oncogene 8, 3343-3351
21. Kulagowski, J. J., Broughton, H. B., Curtis, N. R., Mawer, I. M., Ridgill, M. P., Baker, R., Emms, F., Freedman, S. B., Marwood, R., Patel, S., Ragan, C. I., and Leeson, P. D. (1996) J. Med. Chem. 39, 1941-1942
22. Watanabe, M., Fukaya, M., Sakimura, K., Manabe, T., Mishina, M., and Inoue, Y. (1998) Eur. J. Neurosci. 10, 478-487
23. Yasunaga, M., Yagi, T., Hanzawa, N., Yasuda, M., Yamanashi, Y., Yamamoto, T., Aizawa, S., Miyauchi, Y., and Nishikawa, S. (1996) J. Cell Biol. 132, 91-99
24. Boulay, D., Depoortere, R., Oblin, A., Sanger, D. J., Schoemaker, H., and Perrault, G. (2000) Eur. J. Pharmacol. 391, 63-73
25. Lorenc-Koci, E., Wolfarth, S., and Ossowska, K. (1996) Exp. Brain Res. 109, 268-276
26. Yuasa, S. (1996) Anat. Embryol. 194, 223-234
27. Uchino, S., Watanabe, W., Nakamura, T., Shuto, S., Kazuta, Y., Matsuda, A., Nakajima-Iijima, S., Kudo, Y., Kohsaka, S., and Mishina, M. (2001) FEBS Lett. 506, 117-122
28. Cepeda, C., Buchwald, N. A., and Levine, M. S. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9576-9580
29. Millan, M. J., Dekeyne, A., Rivet, J. M., Dubuffet, T., Lavielle, G., and Brocco, M. (2000) J. Pharmacol. Exp. Ther. 293, 1063-1073
30. Miyakawa, T., Yagi, T., Kagiyama, A., and Niki, H. (1996) Brain Res. Mol. Brain Res. 37, 145-150
31. Miyakawa, T., Yagi, T., Watanabe, S., and Niki, H. (1994) Brain Res. Mol. Brain Res. 27, 179-182
32. Hironaka, N., Yagi, T., and Niki, H. (2002) Brain Res. Mol. Brain Res. 98, 102-110
33. Xu, W., Doshi, A., Lei, M., Eck, M. J., and Harrison, S. C. (1999) Mol. Cell 3, 629-638
34. Takasu, M. A., Dalva, M. B., Zigmond, R. E., and Greenberg, M. E. (2002) Science 295, 491-495
35. de Souza, I. E., and Meredith, G. E. (1999) Synapse 32, 243-253
36. Dragunow, M., Robertson, G. S., Faull, R. L., Robertson, H. A., and Jansen, K. (1990) Neuroscience 37, 287-294
37. Ziolkowska, B., and Hollt, V. (1993) Neurosci. Lett. 156, 39-42
38. Olney, J. W., and Farber, N. B. (1995) Arch. Gen. Psychiatry 52, 998-1007
39. Tsai, G., and Coyle, J. T. (2002) Annu. Rev. Pharmacol. Toxicol. 42, 165-179
40. Svensson, T. H. (2000) Brain Res. Brain Res. Rev. 31, 320-329
41. Mohn, A. R., Gainetdinov, R. R., Caron, M. G., and Koller, B. H. (1999) Cell 98, 427-436
42. Miller, A. L., Maas, J. W., Contreras, S., Seleshi, E., True, J. E., Bowden, C., and Castiglioni, J. (1993) Biol. Psychiatry 34, 178-187
43. Chen, J. F., Moratalla, R., Impagnatiello, F., Grandy, D. K., Cuellar, B., Rubinstein, M., Beilstein, M. A., Hackett, E., Fink, J. S., Low, M. J., Ongini, E., and Schwarzschild, M. A. (2001) Proc. Natl. Acad. Sci. U. S. A. 98, 1970-1975
44. Saga, Y., Kobayashi, M., Ohta, H., Murai, N., Nakai, N., Oshima, M., and Taketo, M. M. (1999) Genes Cells 4, 219-228
45. Adams, M. R., Brandon, E. P., Chartoff, E. H., Idzerda, R. L., Dorsa, D. M., and McKnight, G. S. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12157-12161
46. Leveque, J. C., Macias, W., Rajadhyaksha, A., Carlson, R. R., Barczak, A., Kang, S., Li, X. M., Coyle, J. T., Huganir, R. L., Heckers, S., and Konradi, C. (2000) J. Neurosci. 20, 4011-4020
47. Yaka, R., Thornton, C., Vagts, A. J., Phamluong, K., Bonci, A., and Ron, D. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 5710-5715
48. Lu, W. Y., Xiong, Z. G., Lei, S., Orser, B. A., Dudek, E., Browning, M. D., and Mac-Donald, J. F. (1999) Nat. Neurosci. 2, 331-338
49. Dwivedi, Y., and Pandey, G. N. (1999) J. Pharmacol. Exp. Ther. 291, 688-704
50. Kotecha, S. A., Oak, J. N., Jackson, M. F., Perez, Y., Orser, B. A., Van Tol, H. H., and MacDonald, J. F. (2002) Neuron 35, 1111-1122
51. Viviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., and Marinovich, M. (2003) J. Neurosci. 23, 8692-8700